Clinical Trial

Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery

Name: Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery — clinical trial record (NCT07163650)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This clinical trial aims to evaluate the weight-loss efficacy and safety of efsubaglutide alfa in patients who remain obese 6 months after metabolic surgery.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-01.

Trial Details

NCT Number	NCT07163650
Lead Sponsor	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions	Obesity, Weight Loss, Metabolic Surgery
Enrollment	60 participants
Start Date	2025-09-16
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-01-27